Many digital health teams over-index on UX and engagement. These are important, but they are not clinical value.
Clinical value is about improving something that matters in care delivery or patient outcomes. Depending on context, this can mean reducing time to decision, improving adherence, preventing deterioration, reducing avoidable visits, or improving patient-relevant outcomes.
Stakeholders also interpret “benefit” differently. A clinician might care about decision quality and safety. A manager might care about throughput and capacity. A patient might care about clarity, support, and reduced burden. If you define benefit only as “people used it”, you will struggle to justify the next step.
A simple way to avoid this confusion is to write two statements:
Example:
UX goal: patients complete a symptom check-in weekly.
Clinical claim: earlier identification of deterioration leads to fewer unplanned escalations.
This separation helps you design the right pilot endpoints and the right evidence narrative for EU funding and partners. It also prevents wasted pilots that show engagement but do not inform adoption decisions.
Worthmed® helps teams define benefit in measurable terms early, starting with evidence benchmarking and stakeholder value mapping, then moving to data analysis or pilots that validate the claim in context.